HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

ovide those resources in part by building the necessary facilities, establishing collaborations with industry, and training new scientists with varying expertise.

Many goals presented in the Research Agenda build on the results of ongoing NIAID research. New smallpox, Ebola and anthrax vaccines have been developed by NIAID researchers or grantees and are now approaching clinical testing. One of the first drugs to help treat smallpox was recently submitted to the FDA for approval, and two recent studies identified important biochemical features of two different anthrax toxins that have provided promising leads for new anthrax drugs. Over the past several years, NIAID scientists and grantees have made tremendous strides in understanding the complex physiology of the bacteria that cause anthrax and plague, for example. The mechanism of pathogenesis of Ebola virus and other agents.is also better understood.

In addition, rapid progress in determining the genetic blueprints of dangerous pathogens has provided a wealth of information on the underlying biology of those organisms.


'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 04, 2018 , ... Urological Associates ... a UroLift® Center of Excellence. The designation recognizes that Dr. Choi has achieved ... a commitment to exemplary care for men suffering from symptoms associated with Benign ...
(Date:11/29/2018)... ... November 29, 2018 , ... Tosoh ... the intention of acquiring full ownership. The transaction was approved by the Board ... November 14, 2018. “We are extremely pleased to team up with Tosoh Bioscience ...
(Date:11/27/2018)... N.J. and CARLSBAD, Calif. (PRWEB) , ... November ... ... John Wiley & Sons. The companies have worked together to integrate the ... TAs and students. The combined offering will be available beginning January of ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... N.H. and PHILADELPHIA (PRWEB) , ... November 08, ... ... 25-year-old control system integrator of custom industrial automation and IT solutions with 140 ... be exhibiting at Automation Fair®, taking place at the Pennsylvania Convention Center on ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial ... trial data collection and management. TrialKit ™, an eClinical platform, has incorporated ... can quickly and easily sign in to the app via facial recognition or ...
(Date:11/5/2018)... NEW YORK (PRWEB) , ... November 05, 2018 ... ... test, is launching live educational support for healthcare professionals through its website, ... support will offer a live chat and video option via the website in ...
(Date:11/3/2018)... N.C. (PRWEB) , ... November 01, 2018 , ... Triangle ... by Inc. Magazine as one of the fastest-growing private companies in the United States, ... Inc. 5000 list ranks private companies based on percentage revenue growth over the previous ...
Breaking Biology Technology:
Cached News: